Trade Insulet Corporation - PODD CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.27 | ||||||||
|
Long position overnight fee
Long position overnight fee
Go to platform | -0.026179% | ||||||||
|
Short position overnight fee
Short position overnight fee
Go to platform | 0.003957% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 167.08 |
| Open | 167.34 |
| 1-Year Change | -47.49% |
| Day's Range | 165.97 - 168.31 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Apr 23, 2024 | 167.08 | 2.16 | 1.31% | 164.92 | 168.51 | 164.87 |
| Apr 22, 2024 | 164.32 | -1.72 | -1.04% | 166.04 | 166.41 | 163.91 |
| Apr 19, 2024 | 166.13 | 0.53 | 0.32% | 165.60 | 166.67 | 161.95 |
| Apr 18, 2024 | 164.45 | -1.85 | -1.11% | 166.30 | 169.01 | 163.73 |
| Apr 17, 2024 | 166.12 | -5.78 | -3.36% | 171.90 | 173.27 | 164.98 |
| Apr 16, 2024 | 172.50 | -0.18 | -0.10% | 172.68 | 174.57 | 167.90 |
| Apr 15, 2024 | 173.83 | -2.06 | -1.17% | 175.89 | 178.19 | 173.67 |
| Apr 12, 2024 | 175.09 | -2.15 | -1.21% | 177.24 | 177.95 | 173.93 |
| Apr 11, 2024 | 179.54 | 1.84 | 1.04% | 177.70 | 179.84 | 174.01 |
| Apr 10, 2024 | 177.31 | 3.54 | 2.04% | 173.77 | 177.44 | 172.20 |
| Apr 9, 2024 | 177.87 | 6.97 | 4.08% | 170.90 | 179.21 | 169.90 |
| Apr 8, 2024 | 169.94 | 4.04 | 2.44% | 165.90 | 169.97 | 164.90 |
| Apr 5, 2024 | 164.88 | 1.98 | 1.22% | 162.90 | 165.81 | 161.51 |
| Apr 4, 2024 | 163.02 | -2.56 | -1.55% | 165.58 | 166.89 | 162.73 |
| Apr 3, 2024 | 164.76 | 1.65 | 1.01% | 163.11 | 165.81 | 163.10 |
| Apr 2, 2024 | 164.00 | -1.91 | -1.15% | 165.91 | 166.68 | 162.90 |
| Apr 1, 2024 | 167.99 | -3.31 | -1.93% | 171.30 | 171.30 | 165.56 |
| Mar 28, 2024 | 171.14 | 1.24 | 0.73% | 169.90 | 172.01 | 168.98 |
| Mar 27, 2024 | 169.07 | 3.60 | 2.18% | 165.47 | 169.13 | 162.42 |
| Mar 26, 2024 | 165.24 | -0.66 | -0.40% | 165.90 | 166.30 | 163.01 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Insulet Corporation Company profile
About Insulet Corporation
Insulet Corporation is primarily engaged in the development, manufacture and sale of its proprietary Omnipod System, a continuous insulin delivery system for people with insulin-dependent diabetes. The Omnipod System includes the Omnipod Insulin Management System (Omnipod), the Omnipod DASHTM Insulin Management System (Omnipod DASH) and its digital mobile Omnipod platform. The Omnipod System features two devices: a small, lightweight, self-adhesive disposable tubeless Omnipod device (Pod) and a Personal Diabetes Manager (PDM). Users has to fill the Pod with insulin and wear directly on the body. It can be worn in multiple locations, including the abdomen, hip, back of upper arm, upper thigh or lower back. The Pod delivers precise, personalized doses of insulin into the body through a small flexible tube, cannula. PDM is a wireless, handheld device that programs the Pod with the user’s personalized insulin-delivery instructions and wirelessly monitors the Pod’s operation.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Insulet Corporation revenues increased 21% to $1.1B. Net income increased from $6.8M to $16.8M. Revenues reflect Omnipod System segment increase of 24% to $651.5M, International Omnipod segment increase of 17% to $359.9M, United States segment increase of 24% to $738.9M, All Other segment increase of 17% to $359.9M. Net income benefited from IE on Capital Financing decrease of 13% to $36.7M (expense).
Equity composition
Common Stock, $.001 Par, 03/12, 100M auth., 45,670,320 issd. Insiders own 0.45%. IPO: 5/07, 7.7M shs.@ $15 per share by JPMorgan, Merrill Lynch & Co., Thomas Weisel Partners LLC and Leerink Swann & Company. PO:11/07, 4.9M shs. @ $23.25 per share by JP Morgan and Merrill Lynch.
| Industry: | Medical Equipment, Supplies & Distribution (NEC) |
100 Nagog Park
ACTON
MASSACHUSETTS 01720-3440
US
News
We’re partnering with Newsquawk
Filter out the noise and focus on the news that matters.
08:32, 23 April 2024
US Earnings Season: Tesla, Alphabet, Meta Platforms and Microsoft
The first lot of Wall Street’s mega-cap tech companies report in the coming week. We preview what to expect from Tesla, Alphabet, Meta, and Microsoft’s quarterly results.
15:56, 22 April 2024
Gold price in 2024: geopolitical tensions and rate-cut expectations keep XAU/USD supported
Investors are keeping a close eye on gold as the conflict in the Middle East escalates with a possibility of a full-scale regional war in the area.
07:56, 17 April 2024
US Earnings Season : JP Morgan, Citigroup, Wells Fargo
The first major US banks report quarterly earnings on Friday, April 12th, 2024. We preview what to expect from JP Morgan, Citigroup, and Wells Fargo's quarterly numbers.
16:03, 11 April 2024
Reserve Bank of New Zealand Preview: Rates expected to remain on hold as inflation fight continues
The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, April 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.
09:22, 11 April 2024
US CPI Preview: US inflation expected to grind lower amid fears about sticky prices
US CPI data is released on Wednesday, 10 April. We preview what to expect from the data, how it could influence US Federal Reserve policy, and analyse the NASDAQ (US Tech 100).
15:11, 9 April 2024
How escalating geopolitical tensions are impacting oil markets
The bullish momentum in oil prices remains strong as escalating geopolitical tensions raise concerns about supply.
13:34, 4 April 2024People also watch
Still looking for a broker you can trust?
Join the 610,000+ traders worldwide that chose to trade with Capital.com